Development of Brain-Derived Bioscaffolds for Neural Progenitor Cell Culture.
Julia C Terek1, Matthew O Hebb2,3, Lauren E Flynn1,3,4
1School of Biomedical Engineering, The University of Western Ontario, London, OntarioN6A 5B9, Canada.
ACS Pharmacology & Translational Science
|February 17, 2023
Summary
Brain extracellular matrix microcarriers promote neural progenitor cell growth and differentiation. These novel biomaterials show promise for neural tissue regeneration and cell therapies targeting remyelination.
Area of Science:
- Biomaterials Science
- Neuroscience
- Regenerative Medicine
Background:
- Brain extracellular matrix (ECM) biomaterials can guide neural tissue regeneration.
- Neural progenitor cell culture requires supportive platforms for survival, proliferation, and differentiation.
Purpose of the Study:
- Develop and characterize microcarriers from decellularized brain tissue (DBT) for neural progenitor cell culture.
- Evaluate the potential of DBT microcarriers for neural tissue regeneration applications.
Main Methods:
- Established a novel detergent-free decellularization protocol for porcine and rat brains, achieving >97% dsDNA reduction while preserving collagens (COLs) and glycosaminoglycans (GAGs).
- Fabricated ECM-derived microcarriers using electrospraying with porcine DBT and control microcarriers from bovine tendon COL, assessing structural and compositional properties.
- Cultured rat brain-derived progenitor cells (BDPCs) on DBT and COL microcarriers in spinner flask bioreactors for 2 weeks, analyzing cell growth, phenotype, and gene expression.
Main Results:
- DBT microcarriers were structurally and biomechanically similar to COL microcarriers but richer in COL types and sulfated GAGs.
- Both microcarrier types supported BDPC attachment and expansion.
- Culture conditions promoted BDPC differentiation towards the oligodendrocyte lineage, suggesting potential for remyelination therapies.
Conclusions:
- ECM-derived microcarriers offer a promising platform for neural cell derivation.
- DBT microcarriers possess unique compositional advantages for neural tissue engineering.
- These findings support further investigation for regenerative medicine applications, particularly in cell therapies for remyelination.


